Saint Luke's Newsroom

Nov. 25, 2021

FOX4: Kansas City man hurt in crash holds blood drive to give back

A young man is counting his blessings this Thanksgiving. He’s also paying it forward after his community helped save his life.
Nov. 24, 2021

KMBC: Johnson County Sheriff's Office spends thousands on new COVID-19 antibody tests

The largest full-time law enforcement agency in Kansas does not require its officers to get the COVID-19 vaccine but it is now offering its deputies a COVID-19 antibody test.
Nov. 24, 2021

Health News You Can Use: Pancreatic Cancer

This week, during Pancreatic Cancer Awareness Month, we are talking to Dr. Addison Tolentino, oncologist at Saint Luke’s Cancer Institute, about how genetic testing is expanding treatment options and a new screening test on the horizon that’s exciting doctors.
Nov. 22, 2021

Giving Tuesday for the Hedrick Medical Center Foundation

The HMC Foundation, the Chillicothe Police Department, and the Chillicothe R-2 School District are in partnership to re-start the D.A.R.E. (Drug Abuse Resistance Education) program in schools. 
Nov. 18, 2021

Health News You Can Use: Staying Healthy This Holiday Season

This week we are talking to Dr. Ginny Boos, Director of Infection Prevention, about vital things to keep in mind while traveling and tips to safely gather with family, friends, and those who are more vulnerable this holiday season.
Nov. 17, 2021

FOX4: Local health experts offer tips for keeping your Thanksgiving COVID-safe

FOX4 talked to Ginny Boos about recommended precautions if you are planning to travel or host a Thanksgiving gathering this year as COVID cases rise.
Nov. 17, 2021

TCTMD: Canagliflozin Improves Quality of Life in HF Patients

Treating heart failure patients with canagliflozin significantly improves quality of life, with the marked benefit observed early and sustained through follow-up, according to the results of the CHIEF-HF trial.
Medscape logo
Nov. 17, 2021

Medscape: Canagliflozin Improves HF Symptoms in Fully Remote Trial

New research reported at the AHA Scientific Sessions 2021 shows that the benefits of sodium-glucose cotransporter-2 (SGLT2) inhibitors on symptoms and quality of life in patients with heart failure extend to canagliflozin.
Nov. 12, 2021

Woman with Type 2 Diabetes in Heart Failure Regains Health at Saint Luke’s Cardiometabolic Center of Excellence

Carmon is living with type 2 diabetes, but her life is much fuller now because of the care she received at Saint Luke’s Cardiometabolic Center of Excellence.